| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.7M | +20.2% |
| R&D Expense | $58.9M | +32.1% |
| SG&A Expense | $40.6M | +40.9% |
| Operating Income | -$106.8M | -41.9% |
| Interest Expense | $972K | -71.7% |
| Pre-tax Income | -$105.4M | +4.1% |
| Income Tax | -$461K | +94.8% |
| Net Income | -$104.9M | -3.9% |
| EPS (Basic) | -$1.15 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $60.0M | -76.3% |
| Current Assets | $186.9M | -31.6% |
| Total Assets | $321.0M | -24.7% |
| Current Liabilities | $30.3M | -10.6% |
| Long-term Debt | $10.9M | +210.2% |
| Total Liabilities | $46.6M | -22.5% |
| Stockholders' Equity | $274.4M | -25.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$81.3M | -34.2% |
| Capital Expenditures | $16.2M | -57.5% |
| Investing Cash Flow | -$127.0M | -88.5% |
| Financing Cash Flow | $5.2M | -98.4% |
| Free Cash Flow | -$97.5M | +1.1% |
| +44.7% |
| EPS (Diluted) | -$1.15 | +44.7% |